Stockreport

RBC Sees Upside Potential in Neumora Therapeutics (NMRA) [Yahoo! Finance]

Neumora Therapeutics, Inc.  (NMRA) 
PDF Neumora Therapeutics, Inc. (NASDAQ:NMRA) from Sector Perform to Outperform and increased its price target from $4 to $7. This increase in price target reflects the fir [Read more]